Therapy Areas: Hereditary Disorders
22 April 2022 - - Health Canada has granted Marketing Authorization for the expanded use of Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include children with cystic fibrosis ages six ...
19 April 2022 - - US-based non-profit organization The Cystic Fibrosis Foundation has invested USD 5m in US-based life science startup Sionna Therapeutics, a company founded in 2019, the group said.
15 February 2022 - - US-based Luminis Health Research Institute in Annapolis MD has dosed the first patient in the Phase 3 expansion of the RESOLUTION Phase 2/3 clinical trial evaluating the efficacy ...
11 February 2022 - - Canada-based neo-biotech Cyclica Inc has launched Perturba Therapeutics Inc. a spin out from the Stagljar Lab at the University of Toronto, Donnelly Centre for Cellular ...
4 February 2022 - Healthcare company Northwestern Medicine on Thursday published in the Journal of the American Medical Association (JAMA) the positive outcomes in the first 30 consecutive COVID-19 pa...
26 January 2022 - - US-based messenger RNA medicines company Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) has received new data from clinical development programs for ARCT-154 and ARCT-165, its ...
Related Headlines